Product information

From Health Canada

New search

Current status:

Marketed

Current status date:

2016-04-26

Original market date: See footnote 1

1996-08-14

Product name:

SODIUM ACETATE INJECTION, USP

DIN:

02139529 Electronic product monograph is not available

Company: 

FRESENIUS KABI CANADA LTD
165 Galaxy Blvd, Suite 100
Toronto
Ontario
Canada  M9W 0C8

Class: 

Human

Dosage form(s):

Solution

Route(s) of administration:

Intravenous

Number of active ingredient(s):

1

Schedule(s):

Ethical  

Biosimilar Biologic Drug:

No

American Hospital Formulary Service (AHFS): See footnote 3

40:12.00   REPLACEMENT PREPARATIONS

Anatomical Therapeutic Chemical (ATC): See footnote 4

B05XA08  SODIUM ACETATE

Active ingredient group (AIG) number:See footnote 5

0113986001

List of active ingredient(s)
Active ingredient(s) Strength
SODIUM ACETATE 328 MG / ML

Application information

Related information

Contact us

Version 3.8.0
Date modified: